Sinocare Inc Market Cap ($1.54 Billion)
Market Cap & Net Worth: Sinocare Inc (300298)
Sinocare Inc market cap. Sinocare Inc (SHE:300298) has a market capitalization of $1.54 Billion (CN¥10.50 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #6913 globally and #1389 in its home market, demonstrating a 1.68% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Sinocare Inc's stock price CN¥18.74 by its total outstanding shares 560267306 (560.27 Million). Also see Sinocare Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Sinocare Inc Market Cap History (2015–2026)
Sinocare Inc market cap history from 2015 to 2026. Data shows growth from $1.40 Billion to $1.54 Billion (1.41% CAGR). Check current stock price of Sinocare Inc for real-time trading data and today's change.
Sinocare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Sinocare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300298 year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.48x
Sinocare Inc's market cap is 0.48 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.49x
Sinocare Inc's market cap is 6.49 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.40 Billion | $645.50 Million | $143.66 Million | 2.18x | 9.78x |
| 2016 | $934.44 Million | $795.84 Million | $115.20 Million | 1.17x | 8.11x |
| 2017 | $1.25 Billion | $1.03 Billion | $257.97 Million | 1.21x | 4.85x |
| 2018 | $811.39 Million | $1.55 Billion | $310.45 Million | 0.52x | 2.61x |
| 2019 | $1.17 Billion | $1.78 Billion | $250.68 Million | 0.66x | 4.68x |
| 2020 | $2.84 Billion | $2.02 Billion | $186.89 Million | 1.41x | 15.20x |
| 2021 | $2.39 Billion | $2.36 Billion | $107.57 Million | 1.01x | 22.21x |
| 2022 | $2.73 Billion | $3.95 Billion | $446.51 Million | 0.69x | 6.11x |
| 2023 | $2.47 Billion | $4.06 Billion | $284.40 Million | 0.61x | 8.70x |
| 2024 | $2.12 Billion | $4.44 Billion | $326.29 Million | 0.48x | 6.49x |
Competitor Companies of 300298 by Market Capitalization
Companies near Sinocare Inc in the global market cap rankings as of November 5, 2026. Also see Sinocare Inc asset portfolio for a full breakdown of the balance sheet.
Key companies related to Sinocare Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Sinocare Inc (2015–2026)
Market capitalization of Sinocare Inc from 2015 to today. Between 2015 and today, Sinocare Inc's market cap moved from $1.40 Billion to $ 1.54 Billion, with a yearly change of 1.41%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.54 Billion | +9.53% |
| 2025 | CN¥1.40 Billion | -33.71% |
| 2024 | CN¥2.12 Billion | -14.46% |
| 2023 | CN¥2.47 Billion | -9.27% |
| 2022 | CN¥2.73 Billion | +14.11% |
| 2021 | CN¥2.39 Billion | -15.89% |
| 2020 | CN¥2.84 Billion | +142.36% |
| 2019 | CN¥1.17 Billion | +44.46% |
| 2018 | CN¥811.39 Million | -35.17% |
| 2017 | CN¥1.25 Billion | +33.94% |
| 2016 | CN¥934.44 Million | -33.49% |
| 2015 | CN¥1.40 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Sinocare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.54 Billion USD |
| MoneyControl | $1.54 Billion USD |
| MarketWatch | $1.54 Billion USD |
| marketcap.company | $1.54 Billion USD |
| Reuters | $1.54 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Sinocare Inc
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People's Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic disease… Read more